a:head bio AG is excited to announce the successful completion of a funding round that has raised $20 million to propel its groundbreaking drug discovery technologies forward. Specializing in the innovative use of human cerebral organoids, a:head is redefining the landscape of neuroscience research. These mini brains, crafted from human stem cells in vitro, intricately mimic key phases of human brain development, including neurogenesis, cellular differentiation, and three-dimensional architecture. The pioneering work of co-founders Madeline Lancaster and Juergen Knoblich, who have secured exclusive licensing from the esteemed Institute of Molecular Biotechnology in Vienna, underpins the company's unique approach. The latest funding will be used to enhance a:head's high-content and high-throughput phenotyping platform, which is essential for developing novel therapeutics targeting central nervous system (CNS) disorders. By leveraging the advanced capabilities of their cerebral organoid technology, a:head aims to create more effective treatment options for debilitating brain conditions, including Alzheimer’s disease, schizophrenia, and autism spectrum disorders. This strategic infusion of capital not only accelerates a:head's R&D initiatives but also positions the company at the forefront of biotechnological advancements in neuroscience. As we embark on this new chapter, a:head is committed to pushing the boundaries of drug discovery and developing therapeutics that can profoundly impact patients' lives, ushering in a new era of precision medicine for CNS disorders.
Revolutionary Brain Organoid Technology: a:head Bio AG Secures Funding for Drug Discovery Innovation
Biotechnology
Get the full a:head bio AG company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Laihua Online
Wuhan Laihua Information and Technology is an Internet leading source of information on educational opportunities for students to study in other countries especially in China. Either prospect is planning to come to China or is already in China for education (self-support or scholarship based) he will probably need one of the ranges of services we provide from Education, Translation, Notarization of legal documents to Internships & Jobs or Medical Tourism etc. It is a comprehensive directory of study abroad programs, including summer study abroad, service learning, intensive language programs and more. Wuhan Laihua Information and Technology first set out to fill the information gap between students with a desire to travel abroad to study and companies offering international programs.
$68.0M Series d
today
NEW ID
NEW ID is the latest subsidiary company of NEW, which has started up since August 2019 for a new digital contents/platform business domain. We are responsible for expanding the contents produced and acquired by NEW into various markets and creating our digital capabilities through partnering with a-lister digital content creators and providers in Korea.
